New company investigates DNA for Lundbeck and seeks out cancer drugs

New Danish company Cobo Technologies assists companies in quality control of DNA changes made by the genome editing tool CRISPR. Now, the founders are planning to use their experience for discovering new cancer drugs.

Photo: Colourbox

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles